Jonas Saal retweetledi

Longitudinal CRP kinetics predicts immunotherapy response in NSCLC! First validation of CRP kinetics in Phase III clinical trial. Great cost-efficient and easy-to-implement tool for therapy monitoring @niklas_kluemper @saal_jonas @IEO_Bonn @UniBonn
Read: bit.ly/3WgZgs3

English

